BRD2 and childhood malignant neoplasm: This study provides strong supporting evidence for the use of serum FSH as a useful surrogate biomarker for spermatogenesis in adult males who have been treated for childhood cancer, however semen analysis should always be encouraged and remains the gold standard test of spermatogenesis.